These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia. De Witte T; Muus P; De Pauw B; Haanen C Cancer; 1990 Sep; 66(5):831-7. PubMed ID: 2386911 [TBL] [Abstract][Full Text] [Related]
6. A Study of Human Leukocyte Antigen Mismatched Cellular Therapy (Stem Cell Microtransplantation) in High-Risk Myelodysplastic Syndrome or Transformed Acute Myelogenous Leukemia. Hu KX; Sun QY; Guo M; Qiao JX; Yu CL; Qiao JH; Dong Z; Sun WJ; Zuo HL; Huang YJ; Cai B; Ai HS Stem Cells Transl Med; 2016 Apr; 5(4):524-9. PubMed ID: 26838271 [TBL] [Abstract][Full Text] [Related]
7. Intensive chemotherapy for patients with myelodysplastic syndromes and acute myelogenous leukaemia younger than 65 years. De Witte T; Muus P; De Pauw B; Haanen C Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():33-5. PubMed ID: 2697396 [TBL] [Abstract][Full Text] [Related]
8. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience. Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450 [TBL] [Abstract][Full Text] [Related]
9. Elderly Patients (Age 70 Years or Older) With Secondary Acute Myeloid Leukemia or Acute Myeloid Leukemia Developed Concurrently to Another Malignant Disease. Collinge E; Loron S; Larcher MV; Elhamri M; Heiblig M; Deloire A; Ducastelle S; Labussière H; Barraco F; Wattel E; Salles G; Paubelle E; Thomas X Clin Lymphoma Myeloma Leuk; 2018 May; 18(5):e211-e218. PubMed ID: 29572159 [TBL] [Abstract][Full Text] [Related]
10. Characteristics and Outcomes of Secondary Acute Myeloid Leukemia and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Multicenter Study From the Thai Acute Leukemia Study Group. Chanswangphuwana C; Polprasert C; Owattanapanich W; Kungwankiattichai S; Tantiworawit A; Rattanathammethee T; Limvorapitak W; Saengboon S; Niparuck P; Puavilai T; Julamanee J; Saelue P; Wanitpongpun C; Nakhakes C; Prayongratana K; Sriswasdi C Clin Lymphoma Myeloma Leuk; 2022 Dec; 22(12):e1075-e1083. PubMed ID: 36117042 [TBL] [Abstract][Full Text] [Related]
11. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001. Mauritzson N; Albin M; Rylander L; Billström R; Ahlgren T; Mikoczy Z; Björk J; Strömberg U; Nilsson PG; Mitelman F; Hagmar L; Johansson B Leukemia; 2002 Dec; 16(12):2366-78. PubMed ID: 12454741 [TBL] [Abstract][Full Text] [Related]
12. Cytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AML. Preiss BS; Bergmann OJ; Friis LS; Sørensen AG; Frederiksen M; Gadeberg OV; Mourits-Andersen T; Oestergaard B; Kerndrup GB; Cancer Genet Cytogenet; 2010 Oct; 202(2):108-22. PubMed ID: 20875873 [TBL] [Abstract][Full Text] [Related]
13. Age related risk of myelodysplastic syndrome and acute myeloid leukemia among breast cancer survivors. Kaplan HG; Malmgren JA; Li CI; Calip GS Breast Cancer Res Treat; 2013 Dec; 142(3):629-36. PubMed ID: 24265034 [TBL] [Abstract][Full Text] [Related]
14. Survival difference between secondary and de novo acute myeloid leukemia by age, antecedent cancer types, and chemotherapy receipt. Sedeta E; Jemal A; Nisotel L; Sung H Cancer; 2024 Jun; 130(11):1952-1963. PubMed ID: 38244208 [TBL] [Abstract][Full Text] [Related]
15. TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases. Ok CY; Patel KP; Garcia-Manero G; Routbort MJ; Peng J; Tang G; Goswami M; Young KH; Singh R; Medeiros LJ; Kantarjian HM; Luthra R; Wang SA J Hematol Oncol; 2015 May; 8():45. PubMed ID: 25952993 [TBL] [Abstract][Full Text] [Related]
16. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. Pedersen-Bjergaard J; Philip P; Larsen SO; Andersson M; Daugaard G; Ersbøll J; Hansen SW; Hou-Jensen K; Nielsen D; Sigsgaard TC Leukemia; 1993 Dec; 7(12):1975-86. PubMed ID: 8255096 [TBL] [Abstract][Full Text] [Related]
17. Secondary acute myeloid leukemia - a single center experience. Szotkowski T; Rohon P; Zapletalova L; Sicova K; Hubacek J; Indrak K Neoplasma; 2010; 57(2):170-8. PubMed ID: 20099982 [TBL] [Abstract][Full Text] [Related]
18. Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia? Larson RA Best Pract Res Clin Haematol; 2007 Mar; 20(1):29-37. PubMed ID: 17336252 [TBL] [Abstract][Full Text] [Related]
19. Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disorders. Chang C; Storer BE; Scott BL; Bryant EM; Shulman HM; Flowers ME; Sandmaier BM; Witherspoon RP; Nash RA; Sanders JE; Bedalov A; Hansen JA; Clurman BE; Storb R; Appelbaum FR; Deeg HJ Blood; 2007 Aug; 110(4):1379-87. PubMed ID: 17488876 [TBL] [Abstract][Full Text] [Related]